retatrutide mechanism of action triple agonist glp-1 gip glucagon LY3437943, a novel glucagon, GIP, and receptor for glycemic control and weight loss: From discovery to clinical proof concept retatrutide phase 3 2025 triple
Pay in 4 interest-free payments of $5.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21
















![glutathione prostate Hyperpolarized [1-13C]Dehydroascorbate MR Spectroscopy in a Murine Model of Cancer: Comparison with 18F-FDG PET Prostate Cancer](https://jnm.snmjournals.org/content/jnumed/54/6/922/F4.large.jpg)











